Nuvalent, Inc.

NasdaqGS:NUVL Stock Report

Market Cap: US$7.8b

Nuvalent Management

Management criteria checks 2/4

Nuvalent's CEO is Jim Porter, appointed in Feb 2020, has a tenure of 5.92 years. total yearly compensation is $17.28M, comprised of 3.6% salary and 96.4% bonuses, including company stock and options. directly owns 0.22% of the company’s shares, worth $17.56M. The average tenure of the management team and the board of directors is 3.8 years and 4.2 years respectively.

Key information

Jim Porter

Chief executive officer

US$17.3m

Total compensation

CEO salary percentage3.63%
CEO tenure5.9yrs
CEO ownership0.2%
Management average tenure3.8yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

Nuvalent: Interesting Product, But Aggressive Valuation

Nov 05

We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely

Jun 16
We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Mar 03
Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation

Nuvalent: A First Look

Jan 22

Nuvalent: A Logical Acquisition Target

Jan 10

Nuvalent: Steps Toward That Favorable Entry Point

Dec 07

Nuvalent: Promising Data Keeps Validating Pipeline And Platform

Sep 23

Nuvalent: Likely Approvals Coming Up Do Not Justify This Valuation

Sep 17

Nuvalent: Making Precise Progress In Its Oncology Pipeline

Jun 24

Nuvalent: NVL-655 Could Bring Blockbuster Potential

Jun 14

Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024

Feb 26

CEO Compensation Analysis

How has Jim Porter's remuneration changed compared to Nuvalent's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$381m

Jun 30 2025n/an/a

-US$343m

Mar 31 2025n/an/a

-US$301m

Dec 31 2024US$17mUS$627k

-US$261m

Sep 30 2024n/an/a

-US$224m

Jun 30 2024n/an/a

-US$174m

Mar 31 2024n/an/a

-US$146m

Dec 31 2023US$9mUS$603k

-US$126m

Sep 30 2023n/an/a

-US$114m

Jun 30 2023n/an/a

-US$100m

Mar 31 2023n/an/a

-US$89m

Dec 31 2022US$5mUS$580k

-US$82m

Sep 30 2022n/an/a

-US$73m

Jun 30 2022n/an/a

-US$66m

Mar 31 2022n/an/a

-US$57m

Dec 31 2021US$5mUS$424k

-US$46m

Sep 30 2021n/an/a

-US$36m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$27m

Dec 31 2020US$759kUS$335k

-US$15m

Compensation vs Market: Jim's total compensation ($USD17.28M) is above average for companies of similar size in the US market ($USD8.28M).

Compensation vs Earnings: Jim's compensation has increased whilst the company is unprofitable.

CEO

Jim Porter (50 yo)

5.9yrs
Tenure
US$17,279,869
Compensation

Dr. James R. Porter, also known as Jim, Ph.D. has been Chief Executive Officer and President of Nuvalent, Inc. since February 1, 2020 and has been Director since February 2020. He joined Nuvalent during co...

Leadership Team

NamePositionTenureCompensationOwnership
James Porter
CEO, President & Director5.9yrsUS$17.28m0.22%
$ 17.6m
Alexandra Balcom
CFO & Treasurer5yrsUS$5.49m0.062%
$ 4.8m
Deborah Miller
Chief Legal Officer & Secretary4.6yrsUS$5.46m0.010%
$ 818.6k
Darlene Noci
Chief Development Officer5yrsUS$5.45m0.062%
$ 4.8m
Christopher Turner
Chief Medical Officer4.8yrsUS$5.55m0.028%
$ 2.2m
Benjamin Lane
Senior Vice President of Technical Operations3.5yrsno datano data
Henry Pelish
Chief Scientific Officer1.5yrsno data0.039%
$ 3.0m
Chelcie Lister
Senior Director of Investor Relations & Corporate Communicationsno datano datano data
Matthew Metivier
Senior Vice President of Human Resources3.8yrsno datano data
John Soglia
Senior Vice President of Translational Development2.9yrsno datano data
Joshua Horan
Senior Vice President of Chemistryless than a yearno datano data
Ruth Adams
Senior Vice President of Clinical Operationsless than a yearno datano data
3.8yrs
Average Tenure
50yo
Average Age

Experienced Management: NUVL's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
James Porter
CEO, President & Director5.9yrsUS$17.28m0.22%
$ 17.6m
Sapna Srivastava
Independent Non-Executive Director4.5yrsUS$460.34k0.0032%
$ 251.5k
Grant Bogle
Independent Director1.1yrsUS$603.04k0%
$ 0
Anna Protopapas
Independent Chairman3.8yrsUS$481.94k0.0032%
$ 251.5k
Pasi Antero Janne
Member of Scientific Advisory Boardno datano datano data
D. Gilliland
Member of Scientific Advisory Boardless than a yearUS$450.92k0%
$ 0
Michael Meyers
Independent Director3.3yrsUS$451.04k0.0032%
$ 251.5k
Cameron Wheeler
Independent Non-Executive Director8.9yrsUS$450.44kno data
Joseph Pearlberg
Independent Non-Executive Director5yrsUS$446.28kno data
David Ross Camidge
Member of Scientific Advisory Boardno datano datano data
Aaron Hata
Member of Scientific Advisory Boardno datano datano data
Nancy Kohl
Member of Scientific Advisory Boardno datano datano data
4.2yrs
Average Tenure
61yo
Average Age

Experienced Board: NUVL's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/02 14:35
End of Day Share Price 2025/12/31 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nuvalent, Inc. is covered by 24 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Colleen KusyBaird
Etzer DaroutBarclays
John NewmanCanaccord Genuity